weight loss medication semaglutide Weight-Loss Drug Wegovy Exceeded Expectations, and Supply FDA Approves Oral Semaglutide: First

Their practical experience will shape perceptions of different AOMs and their relative benefits

6-8 .

This medication works by regulating hunger and boosting metabolism, helping patients manage their weight more effectively

Should patients receiving GLP-1 therapy undergo routine thyroid screening

The constipation pathway: Predominant GLP-1 receptor expression in the colon Slowed peristalsis exceeds the gut's ability to adapt Increased water absorption Hard, infrequent stools The diarrhea pathway: Predominant GLP-1 receptor expression in the small intestine Slowed small bowel transit allows bacterial overgrowth or malabsorption Osmotic load in the colon from unabsorbed nutrients Loose, frequent stools The mixed pathway (most common): Early diarrhea (weeks 1-4) from acute gastric retention and bile acid malabsorption Transition to constipation (weeks 4-12) as colonic adaptation lags behind gastric adaptation Resolution to normal or near-normal bowel habits after 12-16 weeks A 2024 paper in Gut (Acosta et al.) measured GLP-1 receptor density in colonic biopsies from 86 patients starting semaglutide